Pharmacogenomics education, research and clinical implementation in the state of Minnesota

Gout prevalence in the Hmong: a prime example of health disparity and the role of community-based genetic research

(2021) Youssef M Roman et al.   Personalized Medicine

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

(2020) Joel A. Morales-Rosado et al.   CARDIOVASCULAR DRUGS AND THERAPY

Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

(2020) Ann M. Moyer et al.   HUMAN IMMUNOLOGY

Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms

(2020) Boguang Sun et al.   PHARMACOTHERAPY

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

(2019) Larisa H. Cavallari et al.   GENETICS IN MEDICINE

Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups

(2019) Moataz E. Mohamed et al.   AMERICAN JOURNAL OF TRANSPLANTATION

PharmVar GeneReview: CYP2D6

(2019) Charity Nofziger et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol)

(2019) Suzette J Bielinski et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Implementation of wide-scale pharmacogenetic testing in primary care

(2019) Natasha Petry et al.   PHARMACOGENOMICS

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing

(2018) Casey R. Dorr et al.   PHARMACOGENOMICS JOURNAL

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies

(2017) Paul Geeleher et al.   GENOME RESEARCH

Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients

(2017) W S Oetting et al.   PHARMACOGENOMICS JOURNAL

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

(2016) WS Bush et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies MultipleCYP3A5Alleles

(2015) W. S. Oetting et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients

(2015) K Sanghavi et al.   PHARMACOGENOMICS JOURNAL

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

(2009) Werner Schroth   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION